Your browser doesn't support javascript.
loading
A paramyxovirus-like model for Ebola virus bipartite promoters.
Gutsche, Irina; le Mercier, Philippe; Kolakofsky, Daniel.
Afiliação
  • Gutsche I; Institut de Biologie Structurale, Univ Grenoble Alpes, CEA, CNRS, IBS, Grenoble, France.
  • le Mercier P; Swiss-Prot Group, Swiss Institute of Bioinformatics, Centre Médicale Universitaire, Geneva, Switzerland.
  • Kolakofsky D; Department of Microbiology and Molecular Medicine, University of Geneva Medical School, Geneva, Switzerland.
PLoS Pathog ; 16(11): e1008972, 2020 11.
Article em En | MEDLINE | ID: mdl-33152032
ABSTRACT
Paramyxo- and filovirus nucleocapsids (NCs) have bipartite promoters at their 3' ends to initiate RNA synthesis. The 2 elements, promoter element 1 (PE1) and promoter element 2 (PE2), are separated by a spacer region that must be exactly a multiple of 6 nucleotides (nt) long. Paramyxovirus NCs have 13 nucleoprotein (NP) subunits/turn, such that PE1 and PE2 are juxtaposed on the same face of the NC helix, for concerted recognition by the viral polymerase. Ebola virus (EBOV) NCs, in contrast, have 25 to 28 subunits/turn, meaning that PE1 and PE2 cannot be juxtaposed. However, there is evidence that the number of subunits/turn at the 3' end of the EBOV NC is variable. We propose a paramyxovirus-like model for EBOV explaining why there are 8 contiguous copies of the PE2 repeat when 3 are sufficient, why expanding this run to 13 further improves minigenome performance, and why there is a limit to the number of hexa-nt that can be inserted in the spacer region.
Assuntos

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Regiões Promotoras Genéticas / Genoma Viral / Paramyxovirinae / Doença pelo Vírus Ebola / Ebolavirus / Nucleoproteínas Tipo de estudo: Prognostic_studies Limite: Humans Idioma: En Ano de publicação: 2020 Tipo de documento: Article

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Regiões Promotoras Genéticas / Genoma Viral / Paramyxovirinae / Doença pelo Vírus Ebola / Ebolavirus / Nucleoproteínas Tipo de estudo: Prognostic_studies Limite: Humans Idioma: En Ano de publicação: 2020 Tipo de documento: Article